 | Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. In April 2022, the United Kingdom Medicines and Healthcare... 18 KB (1,318 words) - 13:22, 28 March 2024 |
and IC41, therapeutic vaccine against hepatitis C. Valneva along with Dynavax Technologies developed a candidate inactivated whole virus vaccine against... 12 KB (997 words) - 22:21, 31 December 2023 |
| Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. It is licensed to Indian... 16 KB (1,211 words) - 17:20, 19 February 2024 |
| developed by Medigen Vaccine Biologics Corporation in Taiwan, American company Dynavax Technologies, and the U.S. National Institutes of Health. This vaccine... 15 KB (1,455 words) - 14:15, 9 March 2024 |
 | a pact with Baylor College of Medicine, Texas Children's Hospital and Dynavax Technologies to develop a COVID-19 vaccine. The vaccine Corbevax/Bio E... 7 KB (544 words) - 19:46, 25 February 2024 |
 | hepatitis B virus infection (HBV). The applicant for this medicinal product is Dynavax GmbH. It was approved for medical use in the European Union in February... 57 KB (5,164 words) - 14:40, 9 April 2024 |
| vaccine developed by Clover Biopharmaceuticals using an adjuvant from Dynavax technologies. Positive results of Phase I trials for the vaccine were published... 15 KB (1,444 words) - 06:17, 7 January 2024 |
Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600" (PDF). S&P Dow Jones Indices. May... 250 KB (7,604 words) - 14:08, 9 April 2024 |
Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600" (PDF). May 12, 2022. Retrieved May... 227 KB (4,804 words) - 08:53, 3 April 2024 |
United States VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies. Full (1) United Kingdom Emergency (32) Bahrain United Arab... 318 KB (19,351 words) - 20:33, 14 March 2024 |
 | recruited in combination study with lefitolimod and Yervoy. July 2016 "Dynavax Presents Updated Data for SD-101 in Combination with KEYTRUDA(R) (pembrolizumab)... 20 KB (2,551 words) - 21:43, 4 April 2024 |
lymphocytes, TH1 and TH2, and their role in regulating host immune response." Dynavax Technologies Timothy Mosmann (born 1949) United States University of Rochester... 26 KB (335 words) - 06:00, 6 April 2024 |
(bankrupt in 2019), Alnylam Pharmaceuticals, Avertis, Xoma Corporation, Dynavax Technologies Incorporation, Elusys Therapeutics, DynPort Vaccine Company... 25 KB (3,013 words) - 23:31, 11 March 2023 |
| Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate". Dynavax.... 98 KB (20,593 words) - 02:58, 8 March 2024 |
medicines, 1994 to May 2000. Director, American Express, Viacom, Maersk, and Dynavax Technologies Corporation. Member, Advisory Board of Daimler Chrysler and... 12 KB (393 words) - 23:08, 16 November 2023 |
 | subunit that is being developed by BioE, the Baylor College of Medicine, and Dynavax Technologies. On 2 June 2021, the DCGI removed the requirement that India-specific... 140 KB (9,633 words) - 22:56, 3 March 2024 |
application of vaccines by Sanofi Pasteur (Pentacel, DTaP-IPV-Hib) (2007) and by Dynavax (Heplisav, hepatitis B. Murphy served as the CDC representative and subject... 34 KB (3,815 words) - 23:56, 13 April 2024 |
 | Evolution, Avalon Pharmaceuticals, Combichem (acquired by Dupont), Corixa, Dynavax Technologies Corporation, Genesys Therapeutics (merged with Somatix and... 18 KB (1,605 words) - 10:42, 31 July 2023 |
Thierry Boon Ludwig Institute for Cancer Research 2006 Robert L. Coffman Dynavax 2006 Jeffrey Ravetch Rockefeller University 2006 Christophe Benoist Harvard... 10 KB (61 words) - 22:03, 3 July 2023 |